Alexandru Capcelea
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alexandru Capcelea has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Dean Turceanu
Medical School, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania
1 shared publication - Alexandra Mihailescu
Centre of Genomic Medicine, Genetics Discipline, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
1 shared publication - Alin Ionescu
Doctoral School, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
1 shared publication - Mihai Alexandru Săndesc
Department XV-Discipline of Orthopedics and Traumatology, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
1 shared publication - Nicolae Albulescu
Department of Internal Medicine II, Division of Cardiology, Centre for Molecular Research in Nephrology and Vascular Disease, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timișoara, Romania
1 shared publication - Raluca Dumache
Center for Ethics in Human Genetic Identifications, “Victor Babeș” University of Medicine and Pharmacy, 300041 Timisoara, Romania
1 shared publication
Latest Publications
- Open Access
- 30 May 2026
- Published by MDPI AG in Hematology Reports
- Vol. 18 (3) , 37
Perioperative Anemia, Transfusion Practices, and Patient Blood Management: Lessons from the COVID-19 Pandemic
The COVID-19 pandemic exposed vulnerabilities in global blood supply systems and accelerated the adoption of patient blood management (PBM) strategies aimed at optimizing transfusion practices in surgical care. Perioperative anemia is a key contributor to adverse outcomes and is frequently treated with allogeneic blood transfusion (ABT), which carries infectious and immunologic risks. Iron deficiency remains the most common and potentially correctable cause of perioperative anemia. This narrative review examines various approaches to perioperative anemia, strategies to minimize reliance on ABT, and alternatives within the PBM paradigm. Evidence supports the use of iron therapy, erythropoiesis-stimulating agents, antifibrinolytic strategies, and blood conservation techniques to reduce transfusion requirements and improve clinical outcomes. Lessons from the COVID-19 pandemic highlight PBM as a framework to enhance transfusion safety and sustainability. Broader implementation of PBM may improve patient outcomes, reduce unnecessary transfusions, and preserve scarce blood resources.
- 30 May 2026
- Published by MDPI AG in Hematology Reports
- Vol. 18 (3) , 37
Open AccessPerioperative Anemia, Transfusion Practices, and Patient Blood Management: Lessons from the COVID-19 Pandemic
The COVID-19 pandemic exposed vulnerabilities in global blood supply systems and accelerated the adoption of patient blood management (PBM) strategies aimed at optimizing transfusion practices in surgical care. Perioperative anemia is a key contributor to adverse outcomes and is frequently treated with allogeneic blood transfusion (ABT), which carries infectious and immunologic risks. Iron deficiency remains the most common and potentially correctable cause of perioperative anemia. This narrative review examines various approaches to perioperative anemia, strategies to minimize reliance on ABT, and alternatives within the PBM paradigm. Evidence supports the use of iron therapy, erythropoiesis-stimulating agents, antifibrinolytic strategies, and blood conservation techniques to reduce transfusion requirements and improve clinical outcomes. Lessons from the COVID-19 pandemic highlight PBM as a framework to enhance transfusion safety and sustainability. Broader implementation of PBM may improve patient outcomes, reduce unnecessary transfusions, and preserve scarce blood resources.